Description: CLOZARIL is one of the most effective neuroleptics for managing symptoms associated with Schizophrenia. It is estimated that this medication is only used in about 15% of the nearly 70,000 people in Florida diagnosed with Schizophrenia. The major problem is obtaining compliance with the WBC that is required each week to start and then monthly for established patients. The use of the CLIA waived Sysmex XW100 substantially allows for improved compliance with required blood work and also allows for broader use of this advanced neuroleptic in managing symptoms and reducing the need for inpatient hospitalization.